Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort

BACKGROUND: Dialysis patients are at high risk for a severe clinical course after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Safety and early immune responses after mRNA-based vaccination have been reported mostly in patients on hemodialysis (HD), whereas reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Beilhack, Georg, Monteforte, Rossella, Frommlet, Florian, Gaggl, Martina, Strassl, Robert, Vychytil, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674530/
https://www.ncbi.nlm.nih.gov/pubmed/34925359
http://dx.doi.org/10.3389/fimmu.2021.780594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674530/
https://www.ncbi.nlm.nih.gov/pubmed/34925359
http://dx.doi.org/10.3389/fimmu.2021.780594

Ejemplares similares